Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    May 2020
  1. WEIDEN PJ, Claxton A, Kunovac J, Walling DP, et al
    Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  2. DEVOE DJ, Farris MS, Townes P, Addington J, et al
    Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    April 2020
  3. GUINART D, Correll CU
    Antipsychotic Polypharmacy in Schizophrenia: Why Not?
    J Clin Psychiatry. 2020;81.
    PubMed    


  4. CORRELL CU
    Current Treatment Options and Emerging Agents for Schizophrenia.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  5. CORRELL CU
    Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    March 2020
  6. LAURIELLO J
    Prevalence and Impact of Relapse in Patients With Schizophrenia.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  7. ZHANG Y, Wang Q, Reynolds GP, Yue W, et al
    Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  8. PATHAK S, Jiang Y, DiPetrillo L, Todtenkopf MS, et al
    Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  9. GILDEN J, Kamperman AM, Munk-Olsen T, Hoogendijk WJG, et al
    Long-Term Outcomes of Postpartum Psychosis: A Systematic Review and Meta-Analysis.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  10. BRUNETTE MF, Correll CU, O'Malley SS, McDonnell D, et al
    Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  11. PUIG O, Fisher M, Loewy R, Miley K, et al
    Early- Versus Adult-Onset Schizophrenia as a Predictor of Response to Neuroscience-Informed Cognitive Training.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  12. POTKIN SG, Kunovac J, Silverman BL, Simmons A, et al
    Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


  13. LAUGHREN TP
    A Growing Crisis in Schizophrenia Drug Development: Failing Signal Detection at North American and Other Clinical Trial Sites.
    J Clin Psychiatry. 2020;81.
    PubMed    


  14. GOPALAKRISHNAN M, Zhu H, Farchione TR, Mathis M, et al
    The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    February 2020
  15. ANDRADE C
    Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    January 2020
  16. MCEVOY JP, Kremens DE
    Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
    J Clin Psychiatry. 2020;81.
    PubMed     Abstract available


    December 2019
  17. MCEVOY JP
    Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    November 2019
  18. ANDREA S, Papirny M, Raedler T
    Brain Imaging in Adolescents and Young Adults With First-Episode Psychosis: A Retrospective Cohort Study.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    October 2019
  19. WANG DM, Zhang GY, Du XD, Jia QF, et al
    Sex Differences in the Prevalence and Clinical Features of Comorbid Depressive Symptoms in Never-Treated Chinese Patients With First-Episode Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    September 2019
  20. KRIVOY A, Joyce D, Tracy D, Gaughran F, et al
    Real-World Outcomes in the Management of Refractory Psychosis.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


  21. KANE JM, Correll CU
    Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    August 2019
  22. MUSTAFA S, Joober R, Iyer S, Shah J, et al
    Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    July 2019
  23. NIA AB, Mann CL, Spriggs S, DeFrancisco DR, et al
    The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    April 2019
  24. CHEN MH, Pan TL, Huang KL, Hsu JW, et al
    Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


  25. KANE JM, Schooler NR, Marcy P, Achtyes ED, et al
    Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


  26. CUI Y, Kim SW, Lee BJ, Kim JJ, et al
    Negative Schema and Rumination as Mediators of the Relationship Between Childhood Trauma and Recent Suicidal Ideation in Patients With Early Psychosis.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    March 2019
  27. LAURIELLO J, Perkins DO
    Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


  28. FADEN J
    Treatment-Resistant Schizophrenia: A Brief Overview of Treatment Options.
    J Clin Psychiatry. 2019;80.
    PubMed    


  29. KANE JM, Agid O, Baldwin ML, Howes O, et al
    Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    February 2019
  30. LAURIELLO J, Perkins DO
    Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    January 2019
  31. GORDON JA
    NIMH Supports Evidence-Based Treatments for Schizophrenia: A Response to Torrey et al.
    J Clin Psychiatry. 2019;80.
    PubMed    


  32. TORREY EF, Yolken RH, Lamb HR
    NIMH Drug Trials for Schizophrenia.
    J Clin Psychiatry. 2019;.
    PubMed    


  33. CORRELL CU, Potkin SG, Zhong Y, Harsanyi J, et al
    Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


  34. MISDRAHI D, Tessier A, Daubigney A, Meissner WG, et al
    Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    J Clin Psychiatry. 2019;80.
    PubMed     Abstract available


    December 2018
  35. KUMAGAI F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, et al
    Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs.
    J Clin Psychiatry. 2018;80.
    PubMed     Abstract available


    September 2018
  36. ANDRADE C
    The Use of Statins for Antipsychotic Augmentation in Schizophrenia: Examination of Meta-Analyses With Flawed Methods and Conclusions.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


  37. GODIN O, Leboyer M, Schurhoff F, Llorca PM, et al
    Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    July 2018
  38. ZHANG XY, Du X, Yin G, Zhang Y, et al
    Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


  39. CHENGAPPA KNR, Brar JS, Gannon JM, Schlicht PJ, et al
    Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    June 2018
  40. EMSLEY R, Nuamah I, Gopal S, Hough D, et al
    Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence: A Post Hoc Analysis of a Randomized Placebo-Controlled Study.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    May 2018
  41. KEEFE RSE, Harvey PD, Khan A, Saoud JB, et al
    Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    April 2018
  42. LEE EE, Martin AS, Tu X, Palmer BW, et al
    Childhood Adversity and Schizophrenia: The Protective Role of Resilience in Mental and Physical Health and Metabolic Markers.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


  43. HOU CL, Chen MY, Cai MY, Chen ZL, et al
    Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China: Comparisons Within and Between Rural and Urban Areas.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    March 2018
  44. TAKEUCHI H, Fathi A, Thiyanavadivel S, Agid O, et al
    Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    J Clin Psychiatry. 2018;79.
    PubMed     Abstract available


    November 2017
  45. TSOUTSOULAS C, Mulsant BH, Kumar S, Ghazala Z, et al
    Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2017 Nov 28. doi: 10.4088/JCP.17m11523.
    PubMed     Abstract available


  46. ANDRADE C
    Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.17f11998.
    PubMed     Abstract available


  47. DEAN DJ, Bryan AD, Newberry R, Gupta T, et al
    A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.16m11365.
    PubMed     Abstract available


  48. MEKORI-DOMACHEVSKY E, Taler M, Shoenfeld Y, Gurevich M, et al
    Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    J Clin Psychiatry. 2017 Nov 14. pii: 16m11207. doi: 10.4088/JCP.16m11207.
    PubMed     Abstract available


  49. TINKELMAN A, Hill EA, Deligiannidis KM
    Management of New Onset Psychosis in the Postpartum Period.
    J Clin Psychiatry. 2017 Nov 7. pii: 17ac11880. doi: 10.4088/JCP.17ac11880.
    PubMed    


  50. DOWNS JM, Lechler S, Dean H, Sears N, et al
    The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.
    J Clin Psychiatry. 2017 Nov 7. pii: 16m11422. doi: 10.4088/JCP.16m11422.
    PubMed     Abstract available


  51. PERKINS DO
    Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
    J Clin Psychiatry. 2017;78:e1431.
    PubMed     Abstract available


    September 2017
  52. MCEVOY JP, Risinger R, Mykhnyak S, Du Y, et al
    Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.
    J Clin Psychiatry. 2017 Sep 19. pii: 17m11625. doi: 10.4088/JCP.17m11625.
    PubMed     Abstract available


  53. HAIG GM, Wang D, Zhao J, Othman AA, et al
    Efficacy and Safety of the alpha7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11162. doi: 10.4088/JCP.16m11162.
    PubMed     Abstract available


  54. PUIG O, Baeza I, de la Serna E, Cabrera B, et al
    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11122. doi: 10.4088/JCP.16m11122.
    PubMed     Abstract available


  55. SULTAN RS, Olfson M, Correll CU, Duncan EJ, et al
    Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    J Clin Psychiatry. 2017;78:e933-e939.
    PubMed     Abstract available


    June 2017
  56. WEIDEN PJ, Kim E, Bermak J, Turkoz I, et al
    Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
    J Clin Psychiatry. 2017 Jun 20. pii: 16m11308. doi: 10.4088/JCP.16m11308.
    PubMed     Abstract available


    May 2017
  57. WEISER M, Levi L, Burshtein S, Hagin M, et al
    Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2017 May 23. pii: 15m10498. doi: 10.4088/JCP.15m10498.
    PubMed     Abstract available


  58. TOSATO S, Albert U, Tomassi S, Iasevoli F, et al
    A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
    J Clin Psychiatry. 2017;78:e477-e489.
    PubMed     Abstract available


  59. BERNARDINI F, Attademo L, Cleary SD, Luther C, et al
    Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.
    J Clin Psychiatry. 2017;78:572-583.
    PubMed     Abstract available


    April 2017
  60. HAGEN JM, Sutterland AL, Koeter MW, Lutter R, et al
    Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.
    J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972.
    PubMed     Abstract available


    March 2017
  61. ZHENG W, Xiang YT, Yang XH, Xiang YQ, et al
    Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2017 Mar 28. doi: 10.4088/JCP.16r10782.
    PubMed     Abstract available


    February 2017
  62. TAKEUCHI H, Lee J, Fervaha G, Foussias G, et al
    Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    J Clin Psychiatry. 2017;78:223-228.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: